 |
PDBsum entry 6mav
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
6mav
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Complex of tissue inhibitor of metalloproteinase-1 (timp-1) mutant l34g with matrix metalloproteinase-3 catalytic domain (mmp-3cd)
|
|
Structure:
|
 |
Stromelysin-1. Chain: a. Synonym: sl-1,matrix metalloproteinase-3,mmp-3,transin-1. Engineered: yes. Metalloproteinase inhibitor 1. Chain: b. Synonym: erythroid-potentiating activity,epa,fibroblast collagenase inhibitor,collagenase inhibitor,tissue inhibitor of metalloproteinases 1,timp-1.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: mmp3, stmy1. Expressed in: homo sapiens. Expression_system_taxid: 9606. Gene: timp1, clgi, timp. Expression_system_taxid: 9606
|
|
Resolution:
|
 |
|
2.37Å
|
R-factor:
|
0.221
|
R-free:
|
0.298
|
|
|
Authors:
|
 |
M.Raeeszadeh-Sarmazdeh,E.Radisky
|
|
Key ref:
|
 |
M.Raeeszadeh-Sarmazdeh
et al.
(2019).
Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition.
J Biol Chem,
294,
9476-9488.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
28-Aug-18
|
Release date:
|
15-May-19
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chain A:
E.C.3.4.24.17
- stromelysin 1.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage where P1', P2' and P3' are hydrophobic residues.
|
 |
 |
 |
 |
 |
Cofactor:
|
 |
Ca(2+); Zn(2+)
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
294:9476-9488
(2019)
|
|
PubMed id:
|
|
|
|
|
| |
|
Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition.
|
|
M.Raeeszadeh-Sarmazdeh,
K.A.Greene,
B.Sankaran,
G.P.Downey,
D.C.Radisky,
E.S.Radisky.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Tissue inhibitors of metalloproteinases (TIMPs) are natural inhibitors of matrix
metalloproteinases (MMPs), enzymes that contribute to cancer and many
inflammatory and degenerative diseases. The TIMP N-terminal domain binds and
inhibits an MMP catalytic domain, but the role of the TIMP C-terminal domain in
MMP inhibition is poorly understood. Here, we employed yeast surface display for
directed evolution of full-length human TIMP-1 to develop MMP-3-targeting
ultrabinders. By simultaneously incorporating diversity into both domains, we
identified TIMP-1 variants that were up to 10-fold improved in binding MMP-3
compared with WT TIMP-1, with inhibition constants (Ki ) in
the low picomolar range. Analysis of individual and paired mutations from the
selected TIMP-1 variants revealed cooperative effects between distant residues
located on the N- and C-terminal TIMP domains, positioned on opposite sides of
the interaction interface with MMP-3. Crystal structures of MMP-3 complexes with
TIMP-1 variants revealed conformational changes in TIMP-1 near the cooperative
mutation sites. Affinity was strengthened by cinching of a reciprocal
"tyrosine clasp" formed between the N-terminal domain of TIMP-1 and
proximal MMP-3 interface and by changes in secondary structure within the TIMP-1
C-terminal domain that stabilize interdomain interactions and improve
complementarity to MMP-3. Our protein engineering and structural studies provide
critical insight into the cooperative function of TIMP domains and the
significance of peripheral TIMP epitopes in MMP recognition. Our findings
suggest new strategies to engineer TIMP proteins for therapeutic applications,
and our directed evolution approach may also enable exploration of functional
domain interactions in other protein systems.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|